Skip to main content

Domestic Cannabis Is Finally Coming To New Zealand

New Zealand nearly became the third country to pass an adult-use cannabis legalization measure back in 2020. The referendum measure failed by just over 2% of the vote. Had the referendum succeeded, New Zealand would have become the first country on earth to pass a national cannabis legalization measure at the ballot box versus via legislative action. Unfortunately, it proved to be a missed opportunity.

New Zealand was already home to a medical cannabis program, however, the program was very limited. While that will still largely be the case, there’s at least one component of the country’s medical cannabis program that is going to see improvement in the near future.

Government officials in New Zealand have finally granted permission for domestic medical cannabis cultivation. Per Newshub:

The Ministry of Health has just approved homegrown and manufactured medicines – so Kiwis no longer have to rely on imported medicinal cannabis.

This green gold has been given the green light by health officials to be turned into medicine for Kiwis patients.

“It’s something the whole industry has been working towards,” Helius Therapeutics CEO Carmen Doran said.

New Zealand is currently home to roughly three dozen medical cannabis companies, however, they are all operating on an import/export model. Allowing domestic cultivation will likely prove to be a gamechanger for the nation’s emerging cannabis industry.

Cannabis imports and exports will always play a role in the emerging cannabis industry, and should not be avoided entirely. With that being said, no country’s medical cannabis program will never reach its full potential without allowing some form of domestic cultivation.

Why Are Canadian Doctors Still So Unfamiliar With Medical Cannabis?

Despite what some governments around the world may claim, cannabis does indeed possess tremendous medical value, as proven by a growing number of peer reviewed studies and personal testimonies from suffering patients that have successfully treated their condition(s) with cannabis.

Fortunately, more and more cannabis laws are being reformed around the world which is boosting safe access to medical cannabis. For instance, Canada has had a medical cannabis program for several decades now, and is the only G-7 nation to have a nationwide adult-use law on the books.

For some reason, doctors and medical professionals in Canada are still lagging behind when it comes to knowledge of medical cannabis and related topics. Below is more information about it via a news release from NORML:

Montreal, Canada: Despite the federal government having legalized patients’ access to marijuana two decades ago, most Canadian health care providers acknowledge that they possess little knowledge about medical cannabis and almost none report having received any training about it while in medical school.

Survey data published in the journal BMC Complementary Medicine and Therapies reported that 56 percent of respondents felt either “uncomfortable or ambivalent regarding their knowledge of medical cannabis,” and that only six percent of medical professionals received any formal training about it while attending medical school. (By contrast, 60 percent of respondents said that they had   attended either a workshop or a conference on the topic.) Fewer than one-in-three (27 percent) acknowledged being familiar with the regulations surrounding patients’ access to medical cannabis products.

The results are consistent with numerous other surveys from the United States and abroad finding that health professionals seldom receive any formal training about cannabis and that most lack sufficient understanding of the subject.

Authors concluded: “The majority of HCPs [health care practitioners] received little, if any, formal training in cannabinoid-based medicine in medical school or residency, … and nearly one-third were unfamiliar with the requirements for obtaining CMP [cannabis for medical purposes] in Canada. Respondents endorsed discomfort with their knowledge of MC [medical cannabis.] …. These findings suggest that medical training programs must reassess their curricula to enable HCPs to gain the knowledge and comfort required to meet the evolving needs of patients.”

Full text of the study, “Healthcare practitioner perceptions on barriers impacting cannabis prescribing practices,” appears in BMC Complementary Medicine and Therapies. Additional information is available in NORML’s fact sheet, ‘Health Clinicians Attitudes Toward Cannabis.’

BDSA Forecasts $57 Billion Cannabis Market By 2026

A new report from BDSA, an international cannabis industry data company, was published this week which provided new projections and estimates for the emerging global cannabis industry.

“The report projects annual global cannabis sales to grow from $30 billion in 2021 to $57 billion in 2026, a compound annual growth rate (CAGR) of almost 13%.” a press release from BDSA stated.

“Despite an inflationary environment and concerns about recession that dampened consumer spending, legal cannabis sales in the U.S. will reach $27 billion by the end of 2022, a jump of 7% over 2021 sales of $25 billion.” the release went on to state.

“The ‘hockey stick’ trend of sales growth seen in the early years of legal cannabis has passed, and economic and regulatory headwinds are exerting pressure on legal cannabis markets,” said Roy Bingham, CEO of BDSA. “Still, our updated forecast predicts that steady gains in developing U.S. markets will continue to drive single-digit annual growth in total U.S. legal sales in 2022, with continued growth prospects out to 2026.”

As with all cannabis industry projections, the main factor at play is politics. After all, a regulated cannabis industry cannot exist in the first place without cannabis reform. Thankfully, more and more jurisdictions are getting on the right side of history when it comes to cannabis policy.

With 2023 right around the corner, this particular report from BDSA essentially involves a three year window. A lot can happen in the next three years for the emerging global cannabis industry, not the least of which will hopefully be the launch of a regulated adult-use industry in Germany.

Prohibiting International Athletes From Consuming Cannabis Is Ridiculous

Earlier this week news surfaced that the World Anti-Doping Agency will be likely be keeping cannabis on its list of banned substances. The World Anti-Doping Agency (WADA) was established in 1999, initiated by the International Olympic Committee and based in Canada, as an ‘international independent agency composed and funded by the sport movement and governments of the world.’ The goal of the agency is to ‘promote, coordinate, and monitor the fight against drugs in sports.’

Cannabis advocates inside and outside of the professional sports world were hopeful that WADA would remove cannabis from the list of banned substances after controversy erupted regarding U.S. sprinter Sha’Carri Richardson’s suspension last year due to a failed drug test for cannabis. Unfortunately, it’s being reported that the agency plans to maintain the status quo and that the decision to do so will be finalized by the end of this month.

Why Is Cannabis Prohibited?

For the last five years of former NBA All-Star Clifford Robinson‘s amazing life I was lucky enough to be his media and communications director. Clifford, who was suspended several times for cannabis during his playing career and had multiple run ins with law enforcement due to cannabis off the court, was a very popular target for anti-cannabis sports rhetoric. Needless to say, I have come across more anti-cannabis sports talking points than most.

The most popular arguments regarding cannabis prohibition in sports seem to hinge on two things. The first is that cannabis is ‘bad for athletes’ and therefore cannabis should be prohibited. Historically, that was the argument offered up as ‘justification’ for cannabis prohibition as it pertains to athletic competitions. In frustrating irony that talking point is now evolving into a new argument that hinges on the exact opposite premise – that cannabis is too beneficial for athletes, and so therefore it should be prohibited.

The premise of both of those arguments are flawed. For the first argument, that cannabis is ‘harmful for athletes,’ all anyone has to do is look at the ever-increasing body of research that clearly demonstrates the wellness benefits that cannabis provides. The second argument, that cannabis is performance enhancing, requires context. Does cannabis provide wellness benefits? Sure. Does it provide so many benefits to athletes that its on par with anabolic steroids? Clearly that is not the case, and policies need to reflect it.

Evolving World

Arguably the most effective, common sense demand in support of cannabis reform outside of sports is ‘regulate cannabis like alcohol.’ It’s a phrase that has helped reform cannabis laws all over the world, and it’s a concept that should be incorporated in professional sports at all levels too, including competitions overseen by the World Anti-Doping Agency such as the Olympics. ‘On the clock’ intoxication should be the primary concern, and as long as an athlete doesn’t show up to trainings, competitions, and other official matters drunk or stoned then it shouldn’t matter.

Cannabis policies around the world are evolving, and the rules surrounding cannabis use by professional athletes needs to evolve as well. We are seeing some of that in professional sports, with leagues like the National Basketball Association suspending testing and the National Football League revamping its policy. Still, there is a long way to go to get sensible cannabis policies implemented in all areas of society, including athletic competitions, with the recent reported decision by WADA serving as a reminder of that fact.

Switzerland Adult-Use Cannabis Pilot Program Delayed By ‘Quality Issues’

Switzerland has worked to launch a pilot adult-use cannabis program in various jurisdictions, including in Basel where the country’s first pilot program was set to launch today. A pilot program involves making cannabis commerce legal for adult-use purposes for some people in limited instances.

The goal of pilot programs, which are popping up in Europe, is to help countries gain insight into adult-use cannabis policies and regulations at a local level in order to be better suited to craft laws and regulations at the national level.

Denmark already has pilot programs in place and is working to expand pilot programs to more markets within its national borders. The Netherlands also has plans for launching a pilot program, however, that program has experienced a number of setbacks. Unfortunately, it appears that the pilot project in Basel, Switzerland is also experiencing delays. Per Swiss Info:

The ‘Weed Care’ experiment in the city of Basel was supposed to launch on September 15. But it has been put on hold because traces of pesticides were found in some of the supposedly organic plants.

Basel’s health department said on Friday that the delay could last several weeks or even months as products must now be analysed again by an independent body.

On one hand, it would obviously be nice to see the pilot program launching today. Yet, on the other hand, no one wants to consume tainted cannabis products, so a delay is warranted. It is worth noting that Switzerland has allowed the legal sales of low-THC cannabis products nationwide since 2017.

Prohibition Treaties Will Not Stop Cannabis Legalization In Germany

I have helped work on cannabis reform efforts since the late 1990s when medical cannabis reform initiatives were being heavily pursued on the West Coast of the United States. Those efforts culminated in election victories in California in 1996, and Oregon and Washington in 1998. Since that time I have seen cannabis prohibitionists across the U.S. basically recycle their failed talking points and tactics from that era over and over again, and the same thing appears to be happing in Germany right now.

Unless you have been living under a rock then you know that Germany is trending towards launching an adult-use cannabis market, and also that once the launch occurs, Germany’s market is going to be considerably more massive than that of Uruguay and Canada combined. Unfortunately, there are futile attempts ramping up that are geared towards halting the process, with the latest one involving cannabis opponents hurling the idea that cannabis cannot be legalized in Germany ‘due to European treaties.’

Theory Versus Reality

Is Germany bound by European and international treaties, including ones that prohibit cannabis? Yes, obviously. Are Canada and Uruguay also bound by international treaties that prohibit adult-use cannabis commerce, including ones that Germany is also a part of? Also yes. With all of that being said, laws are only as good as the enforcement behind them, and just as the sky did not fall and the international community didn’t perform whatever the global community version of a SWAT raid is on Canada and Uruguay when they launched adult-use cannabis sales, the same will prove to be true in Germany when they inevitably launch adult-use sales within their own borders.

Leading up to legalization in Canada in 2018, Russia tried the ‘what about international treaties’ argument in an attempt to derail Canada’s efforts, to no avail. The same thing happened in Uruguay in 2013 when the United Nations tried the same tactic (and failed). It’s a similar concept that I personally witnessed in the United States when opponents tried and failed with their ‘but cannabis is federally illegal!’ arguments. Bad laws are meant to be broken, and cannabis prohibition is one of the worst public policies in human history.

Even within Europe there are examples of jurisdictions disregarding continental and international treaties when it comes to adult-use cannabis commerce. Late last year Malta passed an adult-use legalization measure, although they have yet to issue any licenses and access there is going to be different compared to what will eventually be implemented in Germany. Regardless, there has been no crackdown in Malta as a result of passing a measure that is in direct defiance of certain treaties. Adult-use cannabis pilot programs area already in place in Denmark, with Switzerland getting ready to launch its own pilot program, and eventually, the Netherlands. Again, international treaties have yet to derail any of those efforts in those European countries.

An Obvious Need For A New Approach

Earlier this month European anti-drug coordinators met in Prague, and Czech National Anti-drug Coordinator Jindřich Vobořil called for a new approach to cannabis policy and regulation in Europe at the continental level.

“We hope it will be a coordinated effort (to regulate the cannabis market). It is impossible not to talk about it on an EU-wide basis. Prohibition has not proved to be effective enough; we need to look for other models of control. A controlled market may be the only possible solution,” Vobořil said according to Euractiv.

Cannabis reform is on the move in Europe and in every other corner of the earth, and with it, the spread of the emerging cannabis industry. Lawmakers and regulators can try all of the delay tactics that they can think of, and it’s likely a safe bet that they certainly will, however, those efforts will always prove to be futile. At best, all it will do is delay the inevitable. The cannabis industry toothpaste is out of the tube and it is not going back in, and it’s beyond time that treaties reflect that undeniable fact and catch up with reality.

Is The Biden White House Waiting On Germany To Move Ahead On Recreational Reform?

The US president is putting off further conversation about American cannabis reform until after the mid-terms. Is he waiting for Germany if not Europe beyond that, to go first?

President Joe Biden’s track record on cannabis reform is very poor. This has not changed since he entered public service in Congress.

The most recent discussion is how fast the Administration might move forward on the reforms it has promised – namely stopping the federal imprisonment of people convicted of non-violent cannabis crimes. In July, six senators sent a letter to Biden to express their frustration over the failure to substantively address the many harms of Drug War policies. They urged Biden to use executive clemency authority to help speed this up.

So far, Biden has ignored such calls. Indeed, according to Marijuana Moment, a leading cannabis policy publication in the US, as of last Friday, the President announced that he was punting any new drug reform policy until after the mid-terms.

Is Biden waiting for other countries to go first?

The Giant Discussion Over International Cannabis Policy Is On

One of the reasons that Biden may be waiting until after the mid-terms, apart from the fact that Democrats seem to be on course to do well in the off-year elections, is that he may be waiting for the conversation in Germany, if not Europe, beyond that, to proceed. It is widely expected that a draft bill of the German cannabis legalization bill will be made public either late this fall or early next year. This, along with the working group of European nations now focused on cannabis legalization (which includes Malta and Luxembourg), is the first international attempt by multiple countries to address both domestic law and international regulation.

One of the thornier issues, according to conventional wisdom, is how countries (and regions like the EU) will move forward to implement recreational reform without thumbing their noses at, or withdrawing completely from, the two main international laws that now make cannabis illegal. Namely, the 1961 Single Convention on Narcotic Drugs and the 1971 Convention on Psychotropic Substances.

Germany, after all is the fourth largest economy on the planet. America is number one, with a GDP five times larger. Nonetheless, the fact that Germany will go first, or so the rumours continue to say out of Berlin, will give political cover to those who have gone before (Canada and Uruguay) as well as those who have yet to take the plunge.

One thing is for sure. In Germany, national politicians are ready for the change, not to mention the German people – and no matter when Biden chooses to proceed, it is almost certain at this point, that Germany will go first.

Members Of German Bundestag Travel To North America To Examine Cannabis Legalization

Eight members of the Bundestag’s Health Committee head to North America to educate themselves about how reform works in both California and Canada

A delegation of eight members of the Bundestag’s Health Committee have landed in North America to examine cannabis legalization as it is done in the US and Canada. The group will be there between September 10-17.

Cannabis legalization will, however, only be part of the discussion. The delegation will also look at how the different countries have dealt with the Pandemic, the healthcare of underprivileged people and digitalization efforts.

The delegation consists of members of the Greens, the CDU/CSU, the SPD, the FDP, Die Linke, and one member of the AfD.

A Coordinated Strategy to Move Forward on Legalization

The move comes as the Bavarian Health Minister and another CSU member of the Bundestag’s health committee have commissioned, and are now promoting, a report from (very conservative) Bundestag lawyers, saying that cannabis legalization will violate EU law.

It also comes as a new Ipsos poll shows that an amazing 61% of Germans surveyed believe that cannabis reform should be legal.

One thing is clear. It is not likely that the current government will shrink from its current course, no matter the political opposition.

The German Vanguard

Internationally, the move to full legalization in Germany, the world’s fourth largest economy, is going to have a knock-on effect just about everywhere – which includes countries far from Europe’s borders.

The reason is that those tasked with reform on a federal level are also grappling, both domestically, and with other countries now on the verge of the same, about how to create a carve-out for cannabis in both European and International law.

On one front this should be relatively easy as the EU has already ruled that CBD at least, is not a narcotic. This means that most of the EU is out of compliance with new EU policy on the same. It also shows a path to legalize higher THC flower.

However, with Germany, Malta and Luxembourg moving forward within the EU (plus Holland and presumably at least Portugal), this will create an international push to address much larger issues – including how to carve cannabis out of international drug control treaties.

There is no way this process is going to be fast enough for patients, recreational users or even the cannabis industry itself. But the good news is that the train has left the station, and there is no turning back.

Political Clashes Over Legalization Continue From Bavarian Politicians

Lawyers for the Bundestag Scientific Service of the Bundestag issue analysis of cannabis legalization, claiming it violates EU law – and the cry is picked up, again, by the conservative state Health Minister in Bavaria

The clash over legalization is getting nasty in Germany. In the last three weeks, in late August, a conservative politician, a CSU member and Klaus Holetschek, the state Health Minister of Bavaria, had called out the federal German Chancellor, Olaf Scholz, for proceeding on cannabis reform even though Scholz admitted that cannabis was not harmless.

Now, on the official website of the state of Bavaria, Holetschek, has issued a press release calling for the government to stop work on the legalization of cannabis – this time quoting a group of Bundestag lawyers who say that German cannabis legalization will run afoul of EU law.

There are several problems with this approach. The first is that yes, at present, EU law does prohibit recreational cannabis use – mirroring international law on the same issue. However, just as CBD was reclassified by the EU as not a narcotic (and German law is now out of compliance with the same), the entire matter is now being considered at a multilateral level across the EU. Using circular logic like this is patently disingenuous.

The second problem with this tactic of course, is that it smacks of special interests within the CSU/CDU, particularly from Bavaria, who seem to want to derail a popular legislative initiative by the current government. This line of reasoning also fails to mention that the group doing this very conservative analysis was tasked to do the same by CSU affiliated health politician Stephan Pilsinger  – a member of the Bundestag’s health committee – and also, not coincidentally, also hailing from Bavaria.

Why Are Conservatives from Bavaria Challenging Government Efforts To Legalize Cannabis?

There are several reasons that the Bavarian CSU appears to be increasingly vocal on the topic of federal cannabis reform. The first, of course, is that the state is known, domestically at least, to be the most conservative in the country. Kind of like a “German Texas.” Cannabis infractions are more harshly punished here than anywhere else in the country.

Beyond this, however, this campaign seems to be motivated as much by anti-cannabis voices from the party that lost control of the government last national election. This effort, in other words, appears to be the effort of a group of conservative politicians, on a state level, to slow down federal reform.

It is not a tactic unknown in the United States. Whether it is likely to work remains unseen. That said, given the statements of the federal Health Minister, Karl Lauterbach of late, that is not likely.